Best Harford County Grants for Nonprofits in Maryland

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Scholar Awards

Objectives

There is a critical need for investigators prepared to conduct clinical and translational research in myasthenia gravis (MG). The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

Award Description

The MGNet Scholar Program provides mentored research training to prepare Scholars for an independent research career in the field of MG. The MGNet Scholar Program is 1 year in duration and selected Scholars receive up to $100,000 to support salary, research costs and didactics with potential for renewal. The program will provide an additional $3,000 to travel to MGNet sites to learn specific skills and/or to scientific meeting(s) to present the results of their research. If available for renewal, the program requires approval after interim report and is contingent on demonstration of adequate progress on the research and career development plan. Indirect costs are not allowed. Scholars are encouraged to transition to NIH (e.g., K award), departmental, or private foundation support for their research and further career development.Research must constitute at least 50% of each Scholar’s professional effort. Each Scholar must form a 2-3-member advisory committee to include a primary mentor, an additional clinician investigator or collaborator, and a MGNet faculty sponsor. The advisory committee will meet with the Scholar at least quarterly to review progress and each Scholar will develop an individual academic career development plan and renew it with the committee at least every 6 months.

The Michael Aurbach Fellowship for Excellence in Visual Art, awarded by the College Art Association, supports artist members with an MFA or equivalent who teach studio classes. This fellowship provides a $7,500 award and conference registration to a qualifying artist, focusing on their artistic work rather than a proposal. It aims to recognize and empower visual arts professionals in academia.

Myasthenia Gravis Rare Disease Network (MGNet)

The Myasthenia Gravis Rare Disease Network (MGNet) is a consortium of academic medical centers partnering with the Myasthenia Gravis Foundation of America and Conquer MG as well as collaborators in other research groups and industry. We are working together to enhance therapeutic development for this rare disease.

Diseases Studied

Myasthenia Gravis (MG) and its subtypes:

• Early-onset acetylcholine receptor (AChR) antibody (Ab) positive MG, which primarily affects women
• Late-onset AChR Ab positive MG with a disease bias towards men
• Paraneoplastic thymoma-associated MG
• Muscle specific kinase (MuSK) Ab positive
• AChR/MuSK antibody negative MG

Goals, Mission, & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

• Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
• Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
• Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
• Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.

Pilot and Feasibility Grants

Objectives

MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development.

The priorities of the Pilot Grant Program are:

• Identification treatment responsive biomarkers
• Assess clinical measures and improve that enhance clinical trial readiness
• Evaluation of therapeutic interventions for one or more of the five distinct sub-types of MG

Pilot studies must be designed to access the resources of MGNet and focused on clinical and translational research, including fulfilling the definition of clinical and translational research and exclusion of animal studies.

Funding

The MGNet expects to fund up to two grants, each at a level of $75,000 (IDCs will be limited to 10% and included in the $75,000). Projects will be funded for 12 months. Selection among the applications received will be based on the recommendations of a review committee. A grant may be renewed for an additional one year with approval of interim report by the same review process and availability of funds. Demonstration of fulfillment of initial aims and justification for additional funding will be required. The request will be required a minimum of three months prior to the initial funding period completion.

The Water and Environment Grant Program by the American Water Charitable Foundation supports innovative community projects aimed at improving watersheds, conserving water, and enhancing access to recreation in underserved areas. Eligible applicants include 501(c)(3) organizations and educational institutions located within American Water's service areas. Projects must be completed within 12 months, and applicants should consider budget feasibility when requesting funds. Certain organizations and projects, such as those not classified as 501(c)(3), are ineligible.

The NewSchools: Teaching Reimagined Grant offers a unique funding opportunity of $150,000 to $250,000 for innovative ideas aimed at reimagining the role of educators and enhancing student outcomes. With a focus on leveraging generative AI, the grant supports early-stage organizations and initiatives that prioritize diverse teaching strategies and community involvement. The application deadline is January 8, 2026, with a priority deadline of December 1, 2025, for updates on eligibility.

The NIDCD Early Career Research (ECR) Award (R21) supports early-stage scientists in establishing independent research careers in areas such as hearing, balance, and language. This grant facilitates small, innovative research projects and aims to generate preliminary data for future R01 applications. It is not intended for thesis work and is designed to enhance research methodologies and technologies in biomedical and behavioral sciences. Applications are due by 5:00 PM local time of the applicant organization.

The Lawrence A. Taylor Research Fund in Petrology and Geochemistry offers financial support to two PhD students demonstrating outstanding research in Petrology and/or Geochemistry. Funded by Dong-Hwa Shin (Dawn) Taylor, this grant aims to alleviate some financial burdens associated with their doctoral studies, fostering excellence in these critical fields. Eligible candidates must be AGU student members currently enrolled in relevant doctoral programs and engaged in applicable research.

The Encompass Health Therapy Grant offers up to $50,000 for research on the effectiveness of therapies in inpatient rehabilitation facilities. This funding aims to enhance understanding of neurological impairments and improve patient outcomes through evidence-based practices. Eligible projects must be conducted in the U.S. or Puerto Rico, require a defined research protocol, and adhere to ethical standards. The grant prioritizes studies on therapy impact, implementation science, and caregiver education, contributing to the advancement of rehabilitation care.

The AHRQ Small Health Services Research Grant Program (R03) invites applications for health services research focused on enhancing healthcare quality and patient safety. This funding opportunity supports diverse research settings, including hospitals and home healthcare. Projects may involve collaboration with various stakeholders such as patients, clinicians, and policymakers. By addressing AHRQ research priorities, this initiative aims to improve healthcare delivery and practice while promoting effective partnerships across the healthcare spectrum.

The AHRQ Health Services Research Projects (R01) aims to fund innovative health services research that aligns with AHRQ's priorities, such as enhancing healthcare quality and safety. This initiative encourages applications from various healthcare settings including hospitals and home care, promoting collaboration among diverse stakeholders like patients and policymakers. By addressing key areas of healthcare delivery improvement, this funding opportunity seeks to foster advancements in patient care and overall health system performance.

The AHRQ Health Services Research Demonstration and Dissemination Grants (R18) aim to support innovative health services research that addresses priorities in quality, safety, and effective healthcare delivery. These grants encourage collaboration among various stakeholders, including patients and policymakers, to enhance healthcare practices across diverse settings. Applications are due by 5:00 PM local time of the applicant organization. This initiative fosters improvements in healthcare outcomes and delivery systems.

The American Urological Association offers Medical Student Fellowships to enhance urological research. This program allows exceptional medical students to engage in mentored research with leading urologic scientists, receiving a stipend of $4,000. The initiative aims to cultivate the next generation of urologic researchers. Importantly, research projects no longer require a full 10-week commitment during summer, providing greater flexibility for participants. This fellowship is a significant opportunity for young investigators to contribute to advancements in urological care.

The American Urological Association's Residency Research Award supports urology residents in their research training, aimed at fostering future leaders in urologic research. Each award provides $10,000 for essential research supplies and resources for projects lasting 3-12 months. Recipients must dedicate 80% of their time to research during this period, ensuring they build a strong foundation for their research careers.

The Researcher–Practitioner Collaboration Grant, offered by the American Speech-Language-Hearing Foundation, supports collaborations between researchers and practitioners focused on improving services for individuals with communication disorders. Grants of $35,000 are available for studies that address clinical problems and enhance evidence-based practices. This funding opportunity encourages partnerships aimed at translating research into practical applications, thereby fostering innovative solutions in communication sciences and disorders within healthcare and educational settings.

The New Century Scholars Research Grant, offered by the American Speech-Language-Hearing Foundation, provides up to four grants of $25,000 each to support innovative research in communication sciences and disorders. This funding opportunity encourages both experienced and new investigators to explore novel ideas and methodologies, including artificial intelligence applications. Researchers must demonstrate potential for independent research, with a focus on significant contributions to the field. Applications are due after completing an Intent to Submit Form by March 5.

The APSF/FAER Mentored Research Training Grant aims to enhance anesthesia patient safety by funding promising anesthesiologists who are within 10 years of their first faculty appointment. This two-year grant, totaling $300,000, supports the development of independent researchers focused on perioperative safety. Recipients must allocate 60% of their time to research and career development. With this initiative, the APSF and FAER seek to cultivate the next generation of safety scientists in anesthesia.

The Investigator Initiated Research (IIR) Grants program by the Anesthesia Patient Safety Foundation aims to enhance patient safety in anesthesia care through innovative research. Grants up to $200,000 (or $300,000 with waiver) are available for projects addressing critical safety issues, with a focus on studies leading to measurable improvements in outcomes. The program encourages collaboration and creativity, prioritizing research that lacks alternative funding sources, while also supporting junior investigators with mentorship opportunities.

The Quality Improvement Awards, sponsored by the Anesthesia Patient Safety Foundation (APSF), aim to enhance patient safety during anesthesia care. This initiative invites current trainees and recent graduates to showcase their quality improvement projects. Winners will receive sponsorship to attend the Stoelting Conference in Massachusetts, where they will present their work. The APSF is committed to promoting a culture of safety and learning in anesthesia, ensuring that no one is harmed by anesthesia care.

The New Investigators Research Grant, offered by the American Speech-Language-Hearing Foundation, supports emerging researchers by funding preliminary studies with a clinical focus in audiology and speech-language pathology. Proposals that incorporate Artificial Intelligence technologies for assessment and treatment are encouraged. Grants of $10,000 are available for one-year projects, fostering innovation and research in communication sciences. Eligible investigators must have completed their doctoral degree within the last five years and must not have received prior external funding.

The Speech Science Research Grant, offered by the American Speech-Language-Hearing Foundation, supports new investigators conducting research in speech science. A $10,000 grant will be awarded to eligible researchers, who must have completed their PhD within the last five years. The funding can be utilized for various research-related expenses, fostering innovative studies and honoring the legacy of researcher Dennis Klatt. The next application cycle will be in 2026.

The American Urological Association's Research Scholar Award offers $40,000 annually for one or two years of mentored research training. This program aims to attract promising young investigators into urologic research, providing essential support to clinical and postdoctoral fellows within five years of completing their doctorate or residency and early career faculty within their first five years. This funding opportunity is crucial for fostering the next generation of urologic researchers.

The AUA Boston Scientific Medical Student Innovation Fellowship, funded by the American Urological Association, aims to nurture future urologic researchers. This fellowship offers a $20,000 stipend for a 12-month research project, engaging medical students in innovative urology research under expert mentorship. The initiative addresses the pressing need for skilled professionals in the urologic research field, ensuring a robust pipeline of talent dedicated to advancing patient care and scientific discovery in urology.

The American Urological Association Rising Stars in Urology Research Award supports physician-scientists in their journey to become independent researchers in urology. By providing supplemental salary support for up to five years, the program ensures awardees maintain protected research time while receiving competitive compensation. This initiative encourages promising researchers to compete for further funding and enhances their training in urologic research, ultimately advancing the field and improving patient care.

The AUA Data Research Grant Program, funded by the American Urological Association Inc, aims to enhance urologic research by fostering a diverse group of dedicated professionals. This initiative focuses on bridging knowledge gaps in urology care and cultivating physician scientists through access to comprehensive data sources and mentorship from AUA Data Committee experts. By supporting innovative research, the program contributes significantly to the advancement of patient care in urology.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on supporting nonprofit organizations that enhance patient access to treatment in cardiovascular and metabolic health. Applications are encouraged for initiatives that promote education, empower patients, and address healthcare disparities. Eligible organizations must be IRS 501(c)(3) certified, with a preference for programs demonstrating measurable outcomes. The funding period for local organizations extends from January to October 15th, while national organizations can apply in September.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on enhancing patient access to treatment in cardiovascular and metabolism areas. Nonprofit organizations classified as 501(c)(3) are eligible to apply for funding. The program emphasizes innovative initiatives that address healthcare disparities and improve patient outcomes through education, advocacy, and support services. Applications are evaluated based on design, capacity, and potential impact, with a preference for programs over event-based funding.

The Therapeutic Giving program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatment and advance health equity, particularly in immunology. Eligible nonprofit organizations can apply for support aimed at improving health outcomes through innovative programs. The initiative prioritizes measurable impacts over fundraising activities, emphasizing the importance of addressing healthcare disparities and promoting disease awareness efforts for diseases like rheumatoid arthritis and psoriasis.